⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Lisa BanchikM.D.

Neurology · Boca Raton, FL 33486

NPI: 1699705863

Share:

59

🔴 High Risk

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribingElevated cost per beneficiaryHigh long-acting opioid rate vs peersElevated antipsychotic prescribing (65+)Extreme fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

6,432

Total Claims

$966K

Drug Cost

187

Beneficiaries

$5,166

Cost/Patient

Risk Score Breakdown 59/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Opioid rate (national percentile)+5
Elderly antipsychotic prescribing+5
High fills per patient+5
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 13,194 Neurology providers

+2412%

Opioid rate vs peers

32.9% vs 1.3% avg

+28%

Cost per patient vs peers

$5,166 vs $4,034 avg

+54%

Brand preference vs peers

14.5% vs 9.4% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 2,412% above the average for Neurology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

📊

Composite risk score of 59/100 places this provider in the "High Risk" category — the top 0.017% of all Medicare Part D prescribers. Multiple independent risk factors are contributing simultaneously.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

32.9%

Opioid Rate

2,113

Opioid Claims

$570K

Opioid Cost

42.0%

Long-Acting Rate

This provider's opioid prescribing rate of 32.9% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

86% generic

Brand: 931 claims · $767K

Generic: 5,501 claims · $199K

Patient Profile

69

Avg Age

59%

Female

1.44

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About